BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 30, 2002
View Archived Issues
BioMarin, Genzyme Complete Rolling BLA For Aldurazyme
As promised, BioMarin Pharmaceutical Inc. put the finishing touches on its rolling biologics license application for Aldurazyme, the enzyme replacement therapy for mucopolysaccharidosis I. (BioWorld Today)
Read More
ZymoGenetics, Wyeth Enter Deal Around IL-13 Cytokine Receptor
Read More
Muscarinic Receptor, Derived From Deadly Mushroom, Retains Opiate Analgesia, Sans Addiction
Read More
FDA Considers Policy To Add Bar Codes To Drugs, Devices
Read More
Durect, Voyager Collaborate To Develop Alzheimer's Treatment
Read More
Protarga To Work With ICOS On Targaceutical Cancer Drugs
Read More
Other News To Note
Read More
Appointments And Advancements
Read More